GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » 5-Year Yield-on-Cost %

Thyrocare Technologies (NSE:THYROCARE) 5-Year Yield-on-Cost % : 6.17 (As of May. 29, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies 5-Year Yield-on-Cost %?

Thyrocare Technologies's yield on cost for the quarter that ended in Mar. 2024 was 6.17.


The historical rank and industry rank for Thyrocare Technologies's 5-Year Yield-on-Cost % or its related term are showing as below:

NSE:THYROCARE' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.72   Med: 3.91   Max: 10.74
Current: 6.17


During the past 10 years, Thyrocare Technologies's highest Yield on Cost was 10.74. The lowest was 0.72. And the median was 3.91.


NSE:THYROCARE's 5-Year Yield-on-Cost % is ranked better than
80.28% of 71 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.36 vs NSE:THYROCARE: 6.17

Competitive Comparison of Thyrocare Technologies's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Thyrocare Technologies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's 5-Year Yield-on-Cost % falls into.



Thyrocare Technologies 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Thyrocare Technologies is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Thyrocare Technologies  (NSE:THYROCARE) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Thyrocare Technologies 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies (NSE:THYROCARE) Business Description

Traded in Other Exchanges
Address
D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines